// App-Quantinova.ai

90 : Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl

Researchers

Presenter

  • Wendy Lim

Principal Investigators

  • Mark Crowther

  • Luqi Wang

  • Christine M. Ribic

  • James D. Douketis

  • Terri Schnurr

  • Cathy Moreau

  • Catherine Clase

  • Marc Rodger

  • Erik Yeo

  • Martine Leblanc

  • Philip McFarlane

Medical Centers

  • Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON, Canada

  • Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada

  • St. Joseph`s Healthcare Hamilton, Hamilton,Canada

  • University of Montreal, Montreal, QC, Canada

  • Department of Medicine, McMaster University, Hamilton, ON, Canada

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

  • McMaster University, Hamilton, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Chronic kidney disease

  • Venous thrombosis

  • Renal disease

Biomarkers

  • N/A

Drug/Treatment

  • Tinzaparin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved